Human study PLS-00025
Augmented Skin Beneficial Effects of Thermus Thermophilus and Bacillus Subtilis Mixed-Culture Ferment Extract by Tripeptide GHK-Cu.
Version 1 · published November 7, 2026 · evidence through November 7, 2026 · research snapshot 2026.1.1 · methodology ev-1 · Automated assessment by AI (claude-opus-5-5 and claude-sonnet-5-5), not reviewed by a person.
Only the abstract was available. Essential methods may be missing, which limits what can be judged.
Reports of this study
Every publication, registration and abstract describing this one study. Participants are counted once.
- Augmented Skin Beneficial Effects of Thermus Thermophilus and Bacillus Subtilis Mixed-Culture Ferment Extract by Tripeptide GHK-Cu.primary · Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2026-08-01 · PMID 42573538 · DOI
Design and participants
- Design
- Other design
- Population
- Human participants in a clinical study of an anti-aging face cream. Number, age, sex and skin characteristics are not described in the abstract.
- Conditions
- Skin aging, Facial wrinkles, Skin barrier function
- Setting
- not stated
- Planned enrollment (registry)
- Not reported
- Enrolled
- Not reported
- Randomized
- Not reported
- Completed follow-up
- Not reported
- Funding
- not stated
- Authors’ conflicts
- not stated
Intervention and comparator
What each group received. Related peptides, analogs and combinations are never treated as the compound itself.
- TBFE + GHK-Cu face cream (intervention) · ghk-cu (combination) · Face cream formulated with TBFE and copper tripeptide-1 (GHK-Cu) as the sole active ingredients · topical · not stated · Not reported assigned
What the authors reported
As stated in the sources. This is the authors’ account, not Peptide Library’s assessment.
Wrinkles
unclear outcome · patient-important · not stated · not stated
- TBFE + GHK-Cu face cream: narrative — Combination reported effective in decreasing wrinkles
Skin barrier condition
unclear outcome · surrogate · not stated · not stated
- TBFE + GHK-Cu face cream: narrative — Combination reported to improve skin barrier conditions
Adverse events
None reported. That is not evidence of safety.
Monitoring: Not reported in the abstract.
The authors concluded (paraphrased): The TBFE plus GHK-Cu combination has anti-aging effects on human skin by targeting inflammation, extracellular matrix and barrier function, and is a promising option for anti-aging skincare.
Peptide Library’s assessment
An automated assessment, made by AI separately from the authors’ conclusions and not reviewed by a person. How risk of bias is assessed.
Limitations
- abstract only: Only the abstract is available. Design, sample size, comparator, measurement methods and numeric results of the clinical study are not reported.
- no control group: The abstract does not mention any vehicle or comparator group in the clinical study, so the effect cannot be attributed to the product.
- confounding: GHK-Cu was combined with a ferment extract in one cream, so any clinical effect of GHK-Cu itself cannot be isolated.
- small or imprecise: No sample size, effect estimates, intervals or p-values are reported for the clinical outcomes.
- other: The macrophage and skin explant findings are in vitro and ex vivo work and do not establish clinical benefit in people.
- funding or conflicts: Funding and conflicts of interest are not reported for this cosmetic formulation study.
Wrinkles: Serious concern (Structured limitations appraisal)
For uncontrolled studies, case series and case reports, where no validated comparative tool applies. It lists limitations; it is not a risk-of-bias rating.
| Control group | Not reported | The abstract does not state whether the clinical study had a vehicle or comparator group. |
|---|---|---|
| Selection of participants | Not reported | Recruitment and eligibility criteria of clinical participants are not described in the abstract. |
| Confounding | Serious concern | The cream contained TBFE plus GHK-Cu, so the contribution of GHK-Cu to wrinkle change is confounded. |
| Follow-up and attrition | Not reported | Duration of use, follow-up and completion numbers are not reported in the abstract. |
| Outcome measurement | Not reported | The abstract does not state how wrinkles were measured or whether assessors were blinded. |
| Completeness of reporting | Serious concern | Only qualitative claims of benefit are given, with no data. |
| Precision | Not reported | No sample size, estimates or measures of uncertainty are reported for the wrinkle outcome. |
| Funding and conflicts of interest | Not reported | Funding and author conflicts of interest are not stated in the record. |
Combination product, unclear comparator and unreported methods give serious concern about attributing wrinkle effects to GHK-Cu.
Version 1 · published November 7, 2026 · evidence through November 7, 2026 · research snapshot 2026.1.1 · methodology ev-1 · Peptide Library structured appraisal pl-1 · Automated assessment by AI (claude-opus-5-5 and claude-sonnet-5-5), not reviewed by a person.
Skin barrier condition: Serious concern (Structured limitations appraisal)
For uncontrolled studies, case series and case reports, where no validated comparative tool applies. It lists limitations; it is not a risk-of-bias rating.
| Control group | Not reported | The abstract does not state whether the clinical study had a vehicle or comparator group. |
|---|---|---|
| Selection of participants | Not reported | Recruitment and eligibility criteria of clinical participants are not described in the abstract. |
| Confounding | Serious concern | The cream combined TBFE and GHK-Cu, so the barrier effects cannot be attributed to GHK-Cu alone. |
| Follow-up and attrition | Not reported | Duration of use, follow-up and completion numbers are not reported in the abstract. |
| Outcome measurement | Not reported | The abstract does not say which barrier parameters were measured or by what instrument. |
| Completeness of reporting | Some concern | Barrier improvement is reported only narratively, without numeric results or prespecification. |
| Precision | Not reported | No sample size, estimates or intervals are reported for skin barrier outcomes. |
| Funding and conflicts of interest | Not reported | Funding and author conflicts of interest are not stated in the record. |
Confounding by co-ingredient and absent methodological detail give serious concern for the barrier outcome.
Version 1 · published November 7, 2026 · evidence through November 7, 2026 · research snapshot 2026.1.1 · methodology ev-1 · Peptide Library structured appraisal pl-1 · Automated assessment by AI (claude-opus-5-5 and claude-sonnet-5-5), not reviewed by a person.
Claims this study informs
- Improves signs of skin aging: eligible for “Wrinkles and skin quality, measured or rated”, indirect evidence
- Is safe for human use: not eligible (insufficient data) for “Adverse events, including skin reactions”
- Very low certainty Wrinkles and skin quality, measured or rated
Where each value comes from
- arms: PMID 42573538, abstract (sentences 4 and 6) · extracted by AI (automated, not verified by a person) · abstract only
- author_conclusion: PMID 42573538, abstract (sentences 8-9) · extracted by AI (automated, not verified by a person) · abstract only
- design: PMID 42573538, abstract (sentence 4) · extracted by AI (automated, not verified by a person) · abstract only
- limitations: PMID 42573538, abstract (sentences 4-7) · extracted by AI (automated, not verified by a person) · abstract only
- outcomes: PMID 42573538, abstract (sentence 7) · extracted by AI (automated, not verified by a person) · abstract only
- population: PMID 42573538, abstract (sentence 7) · extracted by AI (automated, not verified by a person) · abstract only
- results: PMID 42573538, abstract (sentence 7) · extracted by AI (automated, not verified by a person) · abstract only
Version 1 · published November 7, 2026 · evidence through November 7, 2026 · research snapshot 2026.1.1 · methodology ev-1 · Automated assessment by AI (claude-opus-5-5 and claude-sonnet-5-5), not reviewed by a person.
These assessments describe published research. Records marked automated were produced by AI under the published methodology and have not been reviewed by a person; they can contain errors. None of this is medical advice, not a statement about any product’s safety for human use, and not a regulatory approval. Peptide Library’s vendor and partner relationships play no part in them (editorial independence).